Home » News » Work and Career News » MD Rapport Improves Diabetic Depression Care


MD Rapport Improves Diabetic Depression Care

By Senior News Editor
Reviewed by John M. Grohol, Psy.D. on April 10, 2014

MD Rapport Improves Diabetic Depression CarePatient-centered care consists of a trusting and caring relationship between a medical provider and the individual receiving care, a relationship that includes a shared agreement on treatment decisions.

A new study finds this approach helps adult patients with diabetes take and maintain newly prescribed antidepressant medication.

The study, found in the Journal of General Internal Medicine, included 1,500 patients with longstanding diabetes, who were prescribed antidepressants.

“In patients with diabetes, depression has been linked to poor self-management and greater risk of diabetic complications including heart disease, dementia, and early mortality,” said Andrew Karter, Ph.D., research scientist at Kaiser Permanente and senior author of the study.

“Therefore, care providers believe that adherence to prescribed antidepressants is an important aspect of diabetes care. It is striking how strongly providers’ relationships with their patients, particularly establishing trust and the use of shared decision-making, influenced whether patients became ongoing users of the medications prescribed for depression.”

Patients with diabetes who were prescribed an antidepressant medication but did not feel included in treatment decisions were more than twice as likely to never fill the prescription. Patients who felt less trust in their provider were also one-third more likely to never refill their prescription after it was first dispensed and to have poor medication adherence during the 12 months after the initial prescription.

For this study, participants rated the quality of communication with their primary care provider during the preceding 12 months. While 96 percent of the patients filled their new antidepressant prescription at least once, rates of never filling more than doubled (6.1 percent vs. 2.7 percent) among patients who felt less involved in decision-making compared to those who felt more involved.

Shared decision-making also was associated with better adherence later in the course of antidepressant treatment, albeit to a lesser degree, suggesting that patients’ perceptions of involvement in clinical decisions may have particular significance for adherence in the initial stages of new antidepressant treatment.

“These findings build on previous work in the Diabetes Study of Northern California (DISTANCE) cohort, in which we observed lower adherence to antidepressant medications for patients with limited health literacy,” said lead author Amy Bauer, M.D., of the University of Washington School of Medicine.

“Because the quality of provider communication is potentially modifiable, this serves as a promising target for interventions to improve adherence and therefore help patients get an adequate course of antidepressant therapy. Engaging patients in their care by fostering trust and encouraging shared decision-making is an important part of the therapeutic process that physicians can promote.”

Source: Kaiser Permanente

 
Doctor speaking with her patient photo by shutterstock.

 

APA Reference
Nauert, R. (2014). MD Rapport Improves Diabetic Depression Care. Psych Central. Retrieved on October 1, 2014, from http://psychcentral.com/news/2014/04/10/md-rapport-improves-diabetic-depression-care/68331.html